The cancer vaccine landscape: What to know

For decades, researchers have sought to develop vaccines to treat cancer, but progress has been limited by the complexity of the disease, the diversity of cancer types and biological differences among individual patients. Now, a personalized cancer vaccine has succeeded in a phase 3 trial for the first time. Merck and Moderna’s intismeran autogene vaccine, […] The post The cancer vaccine landscape: What to know appeared first on Becker's Hospital Review | Healthcare News & A...